These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 11213925)
21. Dosimetric characteristics of a new 125I brachytherapy source. Gearheart DM; Drogin A; Sowards K; Meigooni AS; Ibbott GS Med Phys; 2000 Oct; 27(10):2278-85. PubMed ID: 11099194 [TBL] [Abstract][Full Text] [Related]
22. Experimental measurements of dosimetric parameters on the transverse axis of a new 125I source. Li Z; Fan JJ; Palta JR Med Phys; 2000 Jun; 27(6):1275-80. PubMed ID: 10902556 [TBL] [Abstract][Full Text] [Related]
23. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms. Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047 [TBL] [Abstract][Full Text] [Related]
24. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator. Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931 [TBL] [Abstract][Full Text] [Related]
25. Dosimetric characteristics of the Pharma Seed model BT-125-I source. Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748 [TBL] [Abstract][Full Text] [Related]
26. On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats. Markman J; Williamson JF; Dempsey JF; Low DA Med Phys; 2001 Feb; 28(2):147-55. PubMed ID: 11243337 [TBL] [Abstract][Full Text] [Related]
27. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator. Poon E; Williamson JF; Vuong T; Verhaegen F Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720 [TBL] [Abstract][Full Text] [Related]
28. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources. Nath R; Meigooni AS; Muench P; Melillo A Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730 [TBL] [Abstract][Full Text] [Related]
29. Prospects for quantitative two-dimensional radiochromic film dosimetry for low dose-rate brachytherapy sources. Le Y; Ali I; Dempsey JF; Williamson JF Med Phys; 2006 Dec; 33(12):4622-34. PubMed ID: 17278815 [TBL] [Abstract][Full Text] [Related]
30. Preclinical evaluation of a novel device for delivering brachytherapy to the margins of resected brain tumor cavities. Stubbs JB; Frankel RH; Schultz K; Crocker I; Dillehay D; Olson JJ J Neurosurg; 2002 Feb; 96(2):335-43. PubMed ID: 11838809 [TBL] [Abstract][Full Text] [Related]
31. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed. Pantelis E; Lymperopoulou G; Papagiannis P; Sakelliou L; Stiliaris E; Sandilos P; Seimenis I; Kozicki M; Rosiak JM Phys Med Biol; 2005 Sep; 50(18):4371-84. PubMed ID: 16148399 [TBL] [Abstract][Full Text] [Related]
32. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed. Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418 [TBL] [Abstract][Full Text] [Related]
33. Monte Carlo and TLD dosimetry of an 192Ir high dose-rate brachytherapy source. Karaiskos P; Angelopoulos A; Sakelliou L; Sandilos P; Antypas C; Vlachos L; Koutsouveli E Med Phys; 1998 Oct; 25(10):1975-84. PubMed ID: 9800706 [TBL] [Abstract][Full Text] [Related]
34. A Monte Carlo evaluation of the dosimetric characteristics of the Best Model 2301 125I brachytherapy source. Sowards KT; Meigooni AS Appl Radiat Isot; 2002 Sep; 57(3):327-33. PubMed ID: 12201138 [TBL] [Abstract][Full Text] [Related]
36. A comparison of HDR near source dosimetry using a treatment planning system, Monte Carlo simulation, and radiochromic film. Amoush A; Luckstead M; Lamba M; Elson H; Kassing W Med Dosim; 2013; 38(2):160-4. PubMed ID: 23246195 [TBL] [Abstract][Full Text] [Related]
37. Self-absorption correction for 32P, 198Au and 188Re stents: dose point kernel calculations versus Monte Carlo. Reynaert N; Häfeli UO Med Phys; 2001 Sep; 28(9):1883-97. PubMed ID: 11585219 [TBL] [Abstract][Full Text] [Related]
38. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy. Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D; Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693 [TBL] [Abstract][Full Text] [Related]
39. Report on the dosimetry of a new design 125Iodine brachytherapy source. Wallace RE; Fan JJ Med Phys; 1999 Sep; 26(9):1925-31. PubMed ID: 10505882 [TBL] [Abstract][Full Text] [Related]
40. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source. Li Z; Palta JR; Fan JJ Med Phys; 2000 May; 27(5):1108-12. PubMed ID: 10841416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]